TeleNCC meaningfully shaped medical decision-making, even w/i a tertiary care center, & supported time-efficient consultations while empowering local care, resulting in a low rate of interhospital transfers.🧠
https://t.co/5UMYKSIJVe
#SCCMNeuro#NeuroICU#NeuroTwitter#NeuroX
So happy to be part of this multifocal ischemic stroke case—challenging, fun, and rewarding. Honored to have it accepted by the American Academy of Neurology 🧠
Sharing our published case report on multifocal bihemispheric ischemic strokes due to unknown thrombotic microangiopathy in the Journal of Neurological Research 🧠
🔗 https://t.co/kPQbysjwgl
#Neurology#Stroke#MedicalResearch#CaseReport#AcademicMedicine
New issue for Journal of Neurology Research out!
Vol. 15, No 4, for December 2025 features 1 Review, 3 articles, and 4 case reports.
Check it out here 👇
https://t.co/duLr7BmefI
#MedTwitter#Neurology#ElmerPress
Rapidly Progressive Multifocal Cerebral Vasculitis Presenting With Bi-Hemispheric Stroke
Read the case report here 👇
https://t.co/eSvIlbtfr9
#MedTwitter#Medicine#Neurology
Our new case report just dropped in Journal of Neurology Research — a young patient with rapidly progressive multifocal vasculitis leading to bilateral strokes. A tough case with important takeaways on early recognition and immune-mediated stroke.
#Neurology#Stroke#MedTwitter
There was an independent association between hematoma edema complex - defined as a composite volume of intraparenchymal hematoma and surrounding edema - and poor outcomes in patients with primary ICH.🧠
https://t.co/0YkKo2p9vw
#SCCMNeuro#NeuroICU#NeuroTwitter#NeuroX
For pts w/ AIS & afib, early DOAC initiation (w/i 4d) ⬇️ risk of recurrent ischaemic stroke, symptomatic ICH, or unclassified stroke w/i 30d. These findings support early DOAC initiation in clinical practice.🧠
https://t.co/2XDZBnbDH2
#SCCMNeuro#NeuroICU#NeuroTwitter#NeuroX
aSAH pts who received IV #milrinone had better outcome & required vasopressor or endovascular therapy less often. Early IV milrinone improved outcomes & reduced the use of other therapies to treat CVS and DCI.🧠
https://t.co/LeMadRcAsb
#SCCMNeuro#NeuroICU#NeuroTwitter#NeuroX
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST) https://t.co/3enhJ7glJ7
Just published! Read about a case of spontaneous intracranial hypotension, a condition of postural headache that results from sagging of the brain owing to a noniatrogenic CSF leak.🧠
https://t.co/7m5za1iaA5
#SCCMNeuro#NeuroICU#NeuroTwitter#NeuroX
Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practice
https://t.co/PmCnpo1l0B
CAR T-cell therapy shows potential not only in treating previously incurable cancers but also in addressing various neurological disorders, including primary brain tumors and autoimmune diseases.
https://t.co/ONKyAb56NI
Vyas et al: Serial Diffusion Tensor Imaging and Rate of Ventricular Blood Clearance in Patients with Intraventricular Hemorrhage
Link: https://t.co/b7B3quUbM1
@neurocritical#neurocritcare